TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer
scientific article published on 12 September 2018
Author/s
author: Bram De Laere, Piet Ost, Els G Everaert, Nick Beije, Pieter-Jan van Dam, Dirk Goossens, Jurgen Del Favero, Prabhakar Rajan, Henrik Grönberg, Johan Lindberg, Stefan Sleijfer
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.